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Abstract 
It is difficult to distinguish gastrointestinal stromal tumors (GISTs) from other types of submucosal 
tumors under conventional gastrointestinal endoscopy. We aimed to detect GISTs by molecular 
fluorescence imaging using a near-infrared (NIR) photosensitizer (IR700)-conjugated anti-c-KIT antibody 
and to treat GISTs by photoimmunotherapy with NIR irradiation as a non-invasive theranostic 
procedure. We also investigated the therapeutic mechanisms.  
Methods: Human GIST cell lines GIST-T1 and GIST-882M were incubated with IR700-conjugated 
anti-c-KIT antibody, IR700-12A8, and observed by confocal laser microscopy. Mice with GIST-T1 
xenografts or rats with orthotopic xenografts were injected with IR700-12A8 or AF488-conjugated 
antibody, and observed under IVIS or autofluorescence imaging (AFI) endoscopy. GIST cells were treated 
with IR700-12A8 and NIR light in vitro and vivo, and cell viability, histology and apoptosis were evaluated.  
Results: Strong red fluorescence of IR700-12A8 was observed on the cell membrane of GIST cells and 
was gradually internalized into the cytoplasm. Tumor-specific accumulation of IR700-12A8 was observed 
in GIST-T1 xenografts in mice. Under AFI endoscopy, a strong fluorescence signal was observed in 
orthotopic GIST xenografts in rats through the normal mucosa covering the tumor. The percentage of 
dead cells significantly increased in a light-dose-dependent manner and both acute necrotic and late 
apoptotic cell death was observed with annexin/PI staining. Cleaved PARP expression was significantly 
increased after IR700-12A8-mediated NIR irradiation, which was almost completely reversed by NaN3. 
All xenograft tumors (7/7) immediately regressed and 4/7 tumors completely disappeared after 
IR700-12A8-mediated NIR irradiation. Histologic assessment and TUNEL staining revealed apoptosis in 
the tumors.  
Conclusion: NIR fluorescence imaging using IR700-12A8 and subsequent NIR irradiation could be a very 
effective theranostic technology for GIST, the underlying mechanism of which appears to involve acute 
necrosis and supposedly late apoptosis induced by singlet oxygen. 
Key words: gastrointestinal stromal tumors (GIST), c-KIT, fluorescence endoscopy, near-infrared 
photoimmunotherapy 
Introduction 
Gastrointestinal stromal tumors (GISTs) are the 
most common submucosal tumors (SMTs) of the 
alimentary tract [1]. SMTs are derived from mesen-
chymal cells and are generally covered with normal 
mucosa. Accordingly, it is difficult to distinguish 
GIST from other types of SMTs by conventional 
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endoscopy. Recently, endoscopic ultrasound-guided 
fine needle aspiration (EUS-FNA) has been developed 
to enable histological diagnosis of GIST, but it 
requires a high degree of technical skill. It is 
particularly difficult to perform EUS-FNA for small 
GISTs <2 cm in diameter. Therefore, GISTs <2 cm are 
merely followed-up periodically without making a 
histological diagnosis [2]. However, some GISTs <2 
cm reportedly show rapid growth and liver metastasis 
[3,4]. Akahoshi and colleagues reported that 23% of 
GISTs <2 cm had moderate risk of recurrence accord-
ing to modified Fletcher classification [5,6]. Therefore, 
a more simple and effective diagnostic technology is 
needed for early diagnosis and therapy of GISTs 
before they develop the potential for malignancy. 
 Positron emission tomography (PET) is 
commonly used for the diagnosis of GISTs [7]; 
however, PET exposes patients to high-dose radiation 
and it is not specific for GISTs: PET detects not only 
GIST but also malignant tumors including lymphoma 
and rhabdomyosarcoma, and even non-malignant 
inflammatory lesions [8,9]. To provide high specificity 
for GIST without radiation exposure, fluorescence 
molecular imaging targeting a specific molecule on 
tumor cells represents an ideal new technology 
[10,11]. To date, there has been only one study on 
fluorescence molecular imaging of GIST involving the 
targeting of c-KIT, a molecule specifically expressed 
on GIST cells [12]. In that study, GIST was visualized 
using Alexa Fluor 488 (AF488)-conjugated anti-c-KIT 
antibody in a murine GIST model under laparoscopy. 
However, it yielded a fairly high rate of false-positive 
signals because of a high degree of autofluorescence 
in background tissues. Near-infrared (NIR) light is 
likely to be much more useful for fluorescence 
imaging because autofluorescence with NIR light is 
very low [13]. Moreover, NIR light can penetrate 
tissues much deeper than visible light. Since GISTs are 
SMTs covered with normal mucosa and more than 
90% of GISTs are specifically positive for c-KIT on the 
cell membrane [14], NIR fluorescence imaging 
targeting c-KIT appears to be the most suitable 
strategy for endoscopic molecular imaging of GIST.  
 Photodynamic therapy (PDT) is a treatment 
used for several types of cancers, including esoph-
ageal cancer, which employs a photosensitizer that is 
activated by exposure to a specific wavelength of 
light. The photosensitizer enters cells and its 
activation causes cell death through production of 
reactive oxygen species (ROS) [15]. However, these 
photosensitizers accumulate not only in tumor cells 
but also in normal tissues, thereby causing severe 
toxicities [16,17]. Recently, photoimmunotherapy 
(PIT), using a photosensitizer combined with an 
antibody against a tumor-specific molecule, has been 
utilized as a new type of PDT and was reported to 
show high selectivity [18–20]. However, the use of PIT 
for GIST has not been reported and the potential 
underlying biological mechanisms are unknown. In 
the present study, we first visualized GIST cells using 
fluorescent NIR photosensitizer-conjugated anti-c- 
KIT antibodies in vitro and in vivo. We then evaluated 
the antitumor activity of PIT, combining a NIR 
photosensitizer and NIR irradiation, on GIST as a 
non-invasive theranostic approach. Moreover, we 
investigated the underlying mechanism of cell death 
induced by PIT.  
Materials and Methods  
Cell culture   
 The human GIST cell lines GIST-T1 and 
GIST-882M were kindly provided by Dr. Taguchi T 
(Kochi University, Kochi, Japan) and Dr. Fletcher JA 
(Brigham and Women’s Hospital and Harvard 
Medical School, Boston, MA), respectively. The 
GIST-T1 cell line, which has a c-KIT exon 11 
heterozygous mutation, was cultured in Dulbecco’s 
modified Eagle medium supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin. 
The GIST-882M cell line, which has a c-KIT exon 13 
homozygous mutation, was cultured in Iscove’s 
modified Dulbecco’s medium supplemented with 
15% FBS, 1% penicillin/streptomycin, and 1% 
amphotericin B. The human colon cancer cell line 
SW620 was purchased from ATCC (Manassas, VA) 
and cultured in RPMI1640 supplemented with 10% 
FBS. All cells were maintained at 37°C and 5% CO2 in 
a humidified incubator. 
Synthesis of IR700-conjugated antibodies 
 Mouse anti-human c-KIT monoclonal antibodies 
that recognize the extracellular domain of c-KIT, 12A8 
(Immuno-Biological Laboratories, Takasaki, Japan), 
K45 (Thermo Fisher Scientific, Waltham, MA), 104D2 
(BioLegend, San Diego, CA), or YB5.B8 (BD 
Biosciences, San Diego, CA) were used. These 
antibodies were conjugated with IRDye700 using 
IRDye® 700DX Protein Labeling Kit (LI-COR 
Biosciences, Lincoln, NE). Briefly, each anti-c-KIT 
antibody (100 µg) was incubated with 7 µg of 
IRDye700DX (IR700) NHS ester in phosphate buffered 
saline (PBS) containing 100 mM potassium phosphate 
(pH 8.5) at room temperature for 2 h. The 
IR700-conjugated antibody was purified using ZebaTM 
Desalting Spin Columns, 7K MWCO (Thermo Fisher 
Scientific, Waltham, MA). The protein concentration 
was calculated from absorbance at 280 nm and 689 nm 
according to the following formula described in the 
manufacturer’s instructions. 
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Protein conc. �mgmL� =  A280 − (0.095 × A689)
ƐProtein
× MWProtein × dilution factor 
The dye per protein ratio was calculated as 
described previously [21], and was approximately 2.0. 
 The conjugated antibodies were characterized 
by non-reducing SDS polyacrylamide gel electro-
phoresis (SDS-PAGE) and matrix-assisted laser 
desorption/ionization time-of-flight mass spectrum-
etry (MALDI-TOF MS) analysis (Fig. S1). The purity 
of the conjugates was confirmed by fluorescence 
imaging with a ChemiDocTM MP Imager (Bio-Rad, 
Hercules, CA) as well as Coomassie blue staining 
imaging of non-reducing SDS-PAGE. MALDI-TOF 
MS analysis with an AutoflexTM speed (Bruker, 
Billerica, MA) also confirmed the purity of conjugates 
and appropriate labeling.  
In addition, we labeled 12A8 or IR700-12A8 with 
AF488 to compare the c-KIT affinity of AF488-12A8 
and AF488-IR700-12A8, and confirmed that their 
affinities did not differ, indicating that addition of 
IR700 to 12A8 antibody does not alter the affinity for 
c-KIT (Fig. S2). 
In vitro cell imaging 
For fixed-cell imaging, 1 × 105 cells cultured in 
35-mm glass bottom dishes were fixed with 4% 
paraformaldehyde and blocked with 5% goat serum. 
The cells were incubated with anti-c-KIT antibodies as 
the primary antibody (10 µg/mL) at 4°C overnight 
and were then incubated with goat anti-mouse IgG 
conjugated with Alexa Fluor 488 (Abcam, Cambridge, 
UK) as the secondary antibody for 1 h at room 
temperature, or the cells were incubated with 
IR700-conjugated mouse anti-c-KIT antibodies (10 
µg/mL) at 4°C overnight. After washing with PBS, the 
samples were mounted with ProLong® Gold 
Antifade Reagent with DAPI (Thermo Fisher). 
 For live-cell imaging, the cells were incubated 
with IR700-conjugated anti-c-KIT antibodies (10 
µg/mL) and Hoechst 33342 (Dojindo Laboratories, 
Kumamoto, Japan) in culture media. After washing 
with PBS, phenol red-free RPMI1640 medium was 
added and then fluorescence images were acquired 
with a Nikon A1R using a 638 nm excitation laser and 
700/75-nm band pass emission filter to detect IR700. 
The fluorescence intensity of individual cells was 
quantified using Image J software. At least 100 cells 
were quantified for each cell line and each experiment 
was repeated 3 times. 
In vivo and ex vivo fluorescence imaging 
All animal experiments were performed 
according to the guidelines of the Committee on 
Animal Care and Use of Tokushima University. 
GIST-T1 or SW620 cells (1 × 107) were implanted in 
the flanks of 10 athymic BALB/c nude mice (CLEA 
Japan Inc., Tokyo, Japan). One week after 
implantation, 100 µg of IR700-12A8 was administered 
via the tail vein. Fluorescence images were obtained 
using an IVIS Spectrum (Perkin Elmer Inc., Waltham, 
MA) with a 675/30 nm excitation filter and a 
720/20-nm emission filter. For competition assays, the 
mice were pre-injected with unlabeled 12A8 (300 
µg/mouse) and injected with IR700-12A8 (30 
µg/mouse) at 6 h after pre-injection, as described 
previously [22]. For ex vivo imaging, each organ 
(heart, lung, liver, spleen, kidneys, pancreas and 
gastrointestinal tract) and tumor were resected from 
the mice at 120 h after administration of IR700-12A8 
(100 µg) and ex vivo imaging was performed using the 
IVIS Spectrum. To quantify the fluorescence intensity, 
regions of interest (ROIs) with a diameter of 7 mm 
were selected in each tumor and the background skin, 
and the fluorescence intensities were calculated using 
software provided by the manufacturer. The signal to 
noise (S/N) ratio was calculated as described 
previously [23].  
Fluorescence colonoscopy and ex vivo imaging 
of orthotopic GIST in a rat model 
GIST-T1 cells were orthotopically injected into 
the intestinal tunica muscularis of 4 athymic F344/ 
NJcl-rnu/rnu rats. Four weeks after implantation, the 
rats received AF488-conjugated anti-c-KIT antibodies, 
AF488-conjugated non-specific IgG (IgG1), IR700- 
conjugated 12A8, or IR700-conjugated non-specific 
IgG (IgG1) (2.8 mg/kg, based on our preliminary 
experiments) via the tail vein. Two days later, the rats 
underwent laparotomy under anesthesia with ether 
and the intestine was longitudinally cut open to 
expose submucosal tumors. The tumors from the rats 
injected with AF488-conjugated antibodies were 
observed using a GIF-FQ260Z EVIS LUCERA 
Gastrointestinal Videoscope (Olympus Co., Tokyo, 
Japan), which is able to switch between white light 
and autofluorescence imaging (AFI) modes. The filter 
set for AFI mode selected blue light for excitation at 
390-470 nm, and fluorescence images were obtained 
through the emission barrier filter at 500-630 nm prior 
to detection with a charge coupled device (CCD) 
camera. Tumors from the rats injected with 
IR700-conjugated antibodies were observed using the 
IVIS Spectrum. To evaluate the fluorescence intensity, 
we randomly selected 3 ROIs with a diameter of 1 mm 
in each tumor and the adjacent background mucosa, 
and the average fluorescence intensity was 
quantitated using Image J software. 
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In vitro NIR laser irradiation  
GIST cells (5,000 cells/well) seeded in 96-well 
plates were incubated with IR700-12A8 (10 µg/mL) 
for 6 h at 37°C. After washing with PBS, phenol 
red-free RPMI1640 culture medium was added and 
the cells were irradiated with 0-100 J/cm2 of light at a 
wavelength of 685 nm using a fiber-pigtailed laser 
diode (LP685-SF15, Thorlabs Inc., Newton, NJ), as 
shown in Fig. S3, at a power density of 27.8 mW/cm2. 
Cell viability assay 
Cell viability was accessed by WST-8 assay at 1, 
24, and 48 h after irradiation, as described previously 
[24], and was expressed as the percentage of live cells 
relative to untreated control cells. For cell death 
assessment, GIST-T1 cells were incubated with 10 
µg/mL of IR700-12A8 at 37°C for 6 h, and the media 
was replaced with phenol red-free RPMI1640 medium 
containing 10 mM N-acetyl-L-cysteine (NAC), 10 mM, 
30 mM sodium azide (NaN3), or vehicle. One hour 
after incubation, the cells were irradiated by NIR laser 
at a dose of 20 J/cm2 or 100 J/cm2. Twenty-four hours 
after irradiation, cell viability was evaluated by 
WST-8 assay. The percentage of cell death was 
calculated as 100% minus the percentage of live cells. 
Some of the treated cells were lysed and subjected to 
Western blot analysis for cleaved PARP expression. 
Annexin V-FITC and propidium iodide (PI) 
staining assay 
Apoptotic and necrotic cell death were assessed 
by Annexin V-FITC and PI staining using MEBCYTO® 
Apoptosis Kit (MBL, Nagoya, Japan). Briefly, GIST-T1 
cells treated with vehicle alone, IR700-12A8 (10 
µg/mL) alone, or IR700-12A8 (10 µg/mL) plus NIR 
laser (100 J/cm2) were collected at 1, 6, 12, and 24 h 
after irradiation, washed twice with PBS, and then 
incubated with Annexin V-FITC and PI in the dark. 
They were analyzed by flow cytometry using BD 
FACSVerse (BD Biosciences).  
Western blot analysis 
Total protein samples were prepared in a lysis 
buffer (5 mM MgCl2, 137 mM KCl, 1 mM EDTA, 1 mM 
EGTA, 1% CHAPS, 10 mM HEPES pH 7.5) containing 
protease inhibitor cocktail (Sigma Aldrich Japan, 
Tokyo, Japan). The protein concentration was 
determined using a Pierce BCA Protein Assay Kit 
(Thermo Fisher). Equal amounts of proteins were 
resolved by sodium dodecylsulfate-polyamide gel 
electrophoresis (SDS-PAGE), and transferred to 
polyvinylidene fluoride (PVDF) membranes. The 
membranes were blocked with 5% fat-free dry milk in 
phosphate buffered saline with Tween (PBS-T) for 1 h, 
and incubated with the primary antibodies overnight 
at 4°C. Rabbit anti-human PARP polyclonal antibody 
(Cell Signaling Technology, Boston, MA), rabbit 
anti-human Bcl-2 monoclonal antibody (Cell 
Signaling Technology), or mouse anti-human β-actin 
monoclonal antibody (Sigma Aldrich) were used as 
the primary antibodies. The membranes were washed 
3 times with PBS-T, and incubated with horseradish 
peroxidase (HRP)-conjugated anti-rabbit or mouse 
IgG antibody (GE Healthcare UK Limited, Bucking-
hamshire, UK) for 1 h at room temperature. The 
proteins were visualized by chemiluminescence using 
an ECL detection system (GE Healthcare). 
In vivo NIR laser irradiation in mice 
Fourteen nude mice implanted with GIST-T1 
cells into both the left and right flanks were 
randomized into 2 groups (7 mice per group); one 
group was injected with IR700-12A8 and the other 
with vehicle. IR700-12A8 (100 µg) or vehicle was 
intravenously injected once a week for 2 weeks. The 
right-side tumors were irradiated with 100 J/cm2/day 
of light 3 times weekly after each injection, while the 
left-side tumors were shaded from light. A total of 4 
groups were studied: irradiated right tumors in 
IR700-12A8-injected mice (IR700-12A8 + laser), 
non-irradiated left tumors in IR700-12A8-injected 
mice (IR700-12A8 alone), irradiated right tumors in 
vehicle-injected mice (NIR laser alone), and 
non-irradiated left tumors in vehicle-injected mice 
(vehicle alone), as described in Fig. S4. The tumors 
were irradiated with 100 J/cm2 for 30 min at a power 
density of 55.5 mW/cm2. Tumor volumes were 
measured as described previously [25]. To assess 
tumor disappearance, mice were injected 
intravenously with Alexa Fluor 647-conjugated 
anti-c-KIT antibodies and fluorescence images were 
obtained using the IVIS Spectrum.  
Histological assessment 
Tumors were harvested from mice at days 2, 3, 
and 4. They were fixed in 10% neutral buffered 
formalin and embedded in paraffin. Serial sections 
(3-5 µm) were fixed on glass slides and stained with 
hematoxylin and eosin (H&E). Apoptotic cells were 
detected by terminal deoxynucleotidyl transferase- 
mediated deoxyuridine triphosphate nick-end 
labeling (TUNEL) staining using an In situ Apoptosis 
Detection Kit (Takara Bio Inc., Shiga, Japan) according 
to the manufacturer’s instructions. The sections were 
counterstained with Mayer’s hematoxylin and 
TUNEL-positive cells were quantified in 3 randomly 
selected fields of each section at ×400 magnification. 
Immunohistochemistry 
Immunohistochemical staining was performed 
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using the labeled streptavidin-biotin-peroxidase 
(LSAB) method, as previously described [26]. Briefly, 
paraffin-embedded sections were deparaffinized in 
xylene and hydrated in graded ethanol solutions and 
PBS. Endogenous peroxidase was inactivated by 
incubation with 0.3% H2O2 in methanol. The slides 
were then heated in 0.01 M citrate buffer (pH = 6.0) at 
95°C for 15 min. A rabbit anti-human c-KIT polyclonal 
antibody (Agilent Technologies, Santa Clara, CA) was 
used as primary antibody. The sections were 
incubated with the primary antibody at 4°C 
overnight, washed with PBS, and incubated with 
secondary biotinylated antibody (Sigma Aldrich) for 1 
h at room temperature. Subsequently, the sections 
were incubated with streptavidin-HRP conjugate and 
visualized with DAB chromogen (3’,3-diamino-
benzidine). Finally, the sections were counterstained 
with Mayer’s hematoxylin. 
Statistical analysis 
 Fluorescence intensities of in vitro cell images 
were compared between IR700-12A8 and IR700-K45 
treatment groups using Student’s t test. Fluorescence 
intensities of in vivo and ex vivo images were 
compared between the tumors and background using 
Student’s t test. Cell viability, tumor size, and 
apoptotic index was compared among groups 
receiving vehicle and IR700-12A8 alone, NIR light 
alone, or IR700-12A8 plus NIR light using Dunnett’s 
test. The percentage of dead GIST-T1 cells was 
compared among each of the treatment groups using 
Dunnett’s test. A p-value <0.05 was considered 
significant. 
Results 
In vitro GIST cell imaging using 
IR700-conjugated anti-c-KIT antibodies 
 We first performed a preliminary study using 4 
clones of anti-c-KIT monoclonal antibodies (12A8, 
K45, 104D2, YB5.B8) that target the extracellular 
domains of c-KIT [27–30]. We performed 
immunofluorescence staining on GIST cell lines using 
each antibody and found that 12A8 and K45 had 
higher affinity for c-KIT on GIST cells than did 104D2 
and YB5.B8 (Fig. S5). We also investigated the 
inhibitory effect of these antibodies on GIST cell 
proliferation; however, all the clones exhibited 
similarly weak growth inhibitory effects on both GIST 
cell lines (Fig. S6). Therefore, we selected 12A8 and 
K45 clones in the following experiments. 
 Considering the c-KIT-specific NIR laser therapy 
for GIST, we next performed immunofluorescence 
staining using IRDye700-conjugated 12A8 (IR700- 
12A8) or K45 (IR700-K45). Representative staining 
patterns are shown in Fig. 1A. IR700-12A8 and 
IR700-K45 showed strong red signals in both GIST-T1 
and GIST-882M cells. However, almost no 
fluorescence signals were observed in SW620 colon 
cancer cells, which have negligible c-KIT expression 
[31]. The mean fluorescence intensity with IR700-12A8 
in GIST-T1 (49.0 ± 0.5 cps/cell) was significantly 
higher than with IR700-K45 (47.2 ± 0.6 cps/cell; 
p<0.05). Likewise, the mean fluorescence intensity 
with IR700-12A8 in GIST-882M (74.3 ± 0.9 cps/cell) 
was significantly higher than with IR700-K45 (66.2 ± 
1.8 cps/cell; p<0.01) (Fig. 1B). Therefore, we chose to 
use IR700-12A8 for subsequent GIST imaging 
experiments, even though difference in fluorescence 
intensities was not very large.  
 To observe chronological changes in 
fluorescence signals from live GIST cells, we 
pre-incubated GIST-T1 cells with IR700-12A8 at 4°C, 
and then incubated them at 37°C for 1-6 h. 
Representative images are shown in Figure 1C. A 
strong red signal was observed on the cell membrane 
after pre-incubation (0 h). The signals were then 
gradually translocated to the cytoplasm at 1 h and 2 h. 
Almost all signals were translocated inside the cells at 
6 h. These results strongly suggest that IR700-12A8 
bound to c-KIT on the cell membrane was 
subsequently internalized into the cells. 
In vivo and ex vivo GIST cell imaging in a mouse 
xenograft model 
 To visualize GIST-xenografted mice with 
fluorescence molecular imaging, we administered 
IR700-12A8 into 5 mice implanted with GIST-T1 cells 
in the flank and observed tumors using the IVIS 
Spectrum. A representative imaging pattern is shown 
in Figure 2A. Although NIR fluorescence was 
observed almost throughout the body at 24 h after 
injection, it decreased quickly in the background and 
was confined to the tumor at 48 h. The background 
signal had further decreased and finally only the 
tumor was clearly visualized at 120 h. When 
GIST-xenografted mice were pre-injected with a 
10-fold amount of unlabeled 12A8 (300 µg/mouse) 
followed by IR700-12A8 (30 µg/mouse) for the 
competition assay, the fluorescence signal in the 
tumor was markedly decreased at all timepoints 
observed (Fig. S7), suggesting specific interaction of 
IR700-12A8 with GIST cells. Furthermore, when 
IR700-12A8 was injected into 5 mice bearing GIST-T1 
(right flank) and SW620 (left flank) tumors, no specific 
signal was detected in SW620 tumors, in contrast with 
the strong signal in GIST-T1 tumors, indicating that 
IR700-12A8 bound specifically to c-KIT on GIST-T1 
cells (Fig. 2B). Chronological changes in fluorescence 
intensity in the tumors and background in 5 
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xenografted mice were evaluated. The mean 
fluorescence intensity (± SD) in GIST-T1 tumors 
peaked at 24 h after injection (5886 ± 594 
counts/s/cm2/str), then decreased with time, and 
almost disappeared at 168 h. Similarly, the mean 
intensity in SW620 tumors and the background 
peaked at 24 h (4738 ± 531 counts/s/cm2/str and 3601 
± 296 counts/s/cm2/str), then decreased, and almost 
disappeared at 120 h. However, the intensities in 
GIST-T1 tumors were significantly higher at 24-120 h 
compared with those in SW620 tumors and the 
background (Fig. 2C). The signal to noise (S/N) ratio 
of GIST-T1 tumors increased gradually after injection, 
peaked at 120 h, then subsequently decreased (3.3 ± 
0.2; Fig. 2D). However, the ratio of SW620 tumors was 
0.8-1.5 and did not increase during observation. 
 
 
Figure 1. In vitro cell imaging of GIST-T1 and GIST-882M cells with IR700-conjugated anti-c-KIT antibodies. (A) Representative staining patterns of GIST-T1 and 
GIST-882M cells incubated with IR700-conjugated anti-c-KIT antibodies (IR700-12A8 and IR700-K45). Cells fixed with 4% paraformaldehyde were incubated with 
IR700-conjugated antibody (red) at 4°C overnight. Nuclei were stained with DAPI (blue). SW620 cells were used as a negative control. Original magnification, ×200 
(scale bar, 200 µm). High-magnification images are shown in the inset at the upper right (×600) (scale bar, 50 µm). (B) Mean fluorescence intensity in each individual 
cell. The mean fluorescence intensity of IR700 was quantified using ImageJ software. At least 100 cells were quantified for each cell line and each experiment was 
repeated 3 times. Data represent mean ± standard deviation (SD) (n.s., not significant; *p<0.05, **p<0.01 by Student’s t test). (C) Representative live cell images of 
GIST-T1 cells with IR700-12A8. The cells were pre-incubated with IR700-12A8 for 6 h at 37°C, and were observed at 0, 1, 2, and 6 h after incubation (scale bar, 50 
µm). 
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Figure 2. In vivo fluorescence imaging of GIST-T1 tumors with IR700-12A8. (A) Representative imaging pattern of GIST-T1 xenograft in mice. IR700-12A8 (100 µg) 
was intravenously injected into mice with xenografted GIST-T1 cells and fluorescence images were acquired using an IVIS Spectrum. The yellow arrows indicate 
GIST-T1 tumors. (B) Representative fluorescence images of mice implanted with GIST-T1 cells (right flank, orange arrow) and with SW620 cells (left flank, blue 
arrow) as a negative control tumor. (C) Chronological changes of the mean IR700 fluorescence intensity in GIST-T1 tumors, SW620 tumors, and background skin. 
The regions of interest (ROIs) with a diameter of 7 mm were placed in each of the 5 tumors and the opposite side of background skin, and the mean fluorescence 
intensities were calculated using software provided by the manufacturer. Data represent mean ± SD (n=5; *p<0.05, **p<0.01 by Dunnett’s test). (D) Signal to noise 
(S/N) ratio of IR700 fluorescence in GIST-T1 and SW620 xenograft mice. Data represent mean ± SD (n=5; *p<0.05, **p<0.01 by Student’s t test). 
 
 The ex vivo examination of resected tumors and 
organs revealed strong fluorescence signals in 
GIST-T1 tumors (8083 ± 190 counts/s/cm2/str) but 
weak fluorescence signals in SW620 tumors (2405 ± 
484 counts/s/cm2/str), as well as in the liver (1985 ± 
119 counts/s/cm2/str) and kidneys (1885 ± 98 
counts/s/cm2/str) (Fig. S8). 
Endoscopic fluorescence imaging and ex vivo 
imaging in a rat orthotopic GIST model  
 To visualize orthotopic GIST in nude rats, we 
implanted GIST cells in the intestinal wall to generate 
submucosal tumors, administered AF488-conjugated 
anti-c-KIT antibody or AF488-conjugated non-specific 
IgG, and observed the tumors using an AFI 
colonoscope. Representative images are shown in 
Figure 3A. Typical submucosal tumors, covered with 
normal mucosa, were identified in the colon 4 weeks 
after implantation in both rats. When the colons of 
these rats were opened longitudinally 48 h after 
injection of AF488-conjugated antibody, similar 
submucosal tumors were observed with white-light 
mode under AFI colonoscopy. However, when 
white-light mode was switched over to AFI mode, a 
strong green fluorescence signal appeared on the 
tumor through the normal mucosa covering, although 
only a low autofluorescence signal was observed in 
the surrounding background mucosa in a rat treated 
with AF488-conjugated anti-c-KIT antibody. By 
contrast, a control rat treated with AF488-conjugated 
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non-specific IgG showed only a low autofluorescence 
signal on the tumor, similar to the background signal 
under AFI. The mean fluorescence intensity in the 
tumor of the rat treated with AF488-conjugated 
anti-c-KIT antibody (132.7 ± 8.7 cps/µm2) was 
significantly higher than that in the background 
mucosa (67.0 ± 7.8 cps/µm2; p<0.01) (Fig. 3B), while 
there was no significant difference in fluorescence 
intensity between the tumor and the background 
mucosa in the control rat (71.8 ± 5.4 vs. 67.7 ± 5.2 
cps/µm2). 
We subsequently resected the tumors from rats 
and observed them ex vivo using AFI colonoscopy. A 
strong green fluorescence signal was clearly observed 
on the tumor of the AF488-antibody-injected rat, 
whereas only low autofluorescence signal was 
observed on the tumor of the control rat (Fig. 3A). 
Both tumors were then pathologically confirmed as 
GIST based on the characteristic findings of 
spindle-shaped cells and positivity for c-KIT by 
immunohistochemistry. 
 
 
 
Figure 3. Endoscopic fluorescence imaging and ex vivo imaging of orthotopic GIST-T1 tumors in rats using Alexa Fluor 488 (AF488)-conjugated anti-c-KIT antibody 
or IR700-12A8. (A) Representative endoscopic images of orthotopic GIST-T1 tumors in a rat injected with AF488-conjugated anti-c-KIT antibody (AF488-c-KIT) or 
AF488-conjugated non-specific IgG (AF488-IgG). The tumors were observed with a veterinary endoscope (endoscopic image), in white light-mode with a human AFI 
endoscope (white light), in AFI mode with a human AFI endoscope (AFI in vivo and ex vivo) at 4 weeks after transplantation. White arrows indicate tumors. The tumors 
were then fixed with formalin, embedded in paraffin, and stained with hematoxylin and eosin (H&E), and immunohistochemistry for c-KIT (c-KIT) was performed 
(original magnification, ×200). (B) Mean fluorescence intensities of AF488 in orthotopic tumors and background mucosae of the rats. Data represent mean ± SD (n=3; 
n.s., not significant; **p<0.01 by Student’s t test). (C) Representative ex vivo white-light and fluorescence images of orthotopic GIST-T1 tumors in a rat injected with 
IR700-12A8 or IR700-conjugated non-specific IgG (IR700-IgG). The tumors were observed using the IVIS Spectrum. White arrows indicate tumors. (D) Mean 
fluorescence intensities of IR700 in orthotopic tumors and background mucosae of the rats. Data represent mean ± SD (n=3; n.s., not significant; **p<0.01 by 
Student’s t test). 
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 We also injected rats with IR700-12A8 or 
IR700-conjugated non-specific IgG (IR700-IgG), 
excised the tumors, and then observed them ex vivo 
using the IVIS Spectrum. Representative images are 
shown in Fig. 3C. The rat treated with IR700-12A8 
showed strong fluorescence signals specifically on the 
tumor covered with normal mucosa, while the rat 
treated with IR700-IgG did not show any 
tumor-specific fluorescence signals. The mean 
fluorescence intensity in the tumor of the rat treated 
with IR700-12A8 (8113 ± 1545 counts/s/cm2/str) was 
significantly higher than that in the background 
mucosa (2266 ± 613 counts/s/cm2/str; p<0.01) (Fig. 
3D), whereas no significant difference in fluorescence 
intensity was observed between the tumor and the 
background mucosa in the rat treated with IR700-IgG 
(2620 ± 328 vs. 2108 ± 279 counts/s/cm2/str).  
Antitumor effect of IR700-12A8-mediated PIT 
 Since IR700 is known as a photosensitizer, we 
next treated GIST cells with IR700-12A8 and then 
irradiated them using a NIR laser to investigate the 
efficacy of PIT. Treatment with NIR laser alone or 
IR700-12A8 alone exhibited no effects on GIST-T1 cell 
viability. When cells treated with IR700-12A8 were 
irradiated at 10 J/cm2, the percentage of cell death 
was 8% at 1 h after irradiation and increased to 60% at 
24 h after irradiation (p<0.01) and then to 78% at 48 h 
after irradiation (p<0.01). The cell death percentage 
was increased in a radiation dose-dependent manner, 
reaching 63% at 1 h and 100% at 24 h and 48 h with 
irradiation at 100 J/cm2 (Fig. 4A). 
 Since IR700-12A8-mediated PIT showed strong 
antitumor activity against GIST-T1 in vitro, we 
investigated its in vivo effect in GIST-T1-xenografted 
mice. We first performed in vivo experiments using 
PIT with 50 J/cm2 or 100 J/cm2 of NIR light based on 
dosages established from in vitro experiments (the 
detailed treatment schedule is described in Fig. S9A). 
However, the antitumor effect was limited and the 
tumors continued to grow, although significant tumor 
reduction was observed compared with control (Fig. 
S9). Since no adverse events, including weight loss 
and cutaneous damage, were observed, we then 
performed in vivo PIT with a higher light dose, i.e., 2 
cycles of treatment comprising IR700-12A8 injection 
and 3 rounds of irradiation at 100 J/cm2 (Fig. 4B). To 
establish the protocol, we checked the intact 
fluorescence of IR700 in tumors before the first, 
second, and third 100 J/cm2 irradiation (at 24, 48, and 
72 h after IR700-12A8 injection) and confirmed that 
the intact fluorescence of IR700 existed before the 
second and third irradiation (Fig. S10). Following this 
regimen, the tumor volume of the control group 
increased over time and was approximately 4.9 times 
larger at day 30 than that at day 0. Similarly, the 
tumor volumes in mice treated with IR700-12A8 alone 
or NIR laser alone increased over time and were 
approximately 5.2 times or 5.9 times larger, 
respectively, at day 30. In contrast, the tumor volume 
in mice treated with IR700-12A8-mediated PIT was 
significantly decreased by 35% soon after treatment in 
all mice, and the tumors disappeared completely in 4 
out of 7 mice thereafter (Fig. 4C and Fig. S11). Fig. 4D 
shows results from 2 mice that were treated with 
IR700-12A8 or vehicle and that had 2 xenografts (right 
and left) at day 30, with irradiation of the right-side 
tumor and no irradiation of the left-side tumor. The 
right-side tumor exposed to irradiation alone and the 
left-side tumor treated with IR700-12A8 alone did not 
show any regression and both exhibited strong 
fluorescence signals. However, the right-side tumor 
treated with both IR700-12A8 and irradiation showed 
marked regression, and it exhibited no fluorescence 
signals, suggesting that the tumor disappeared 
completely. Fig. 4E shows excised tumors from each 
mouse at day 30. Tumors from mice treated with 
vehicle alone, NIR laser alone, or IR700-12A8 alone 
were of comparable size. In contrast, no tumors were 
observed in 4 mice, and very small tumors (5-6 mm) 
were observed in 3 mice treated with 
IR700-12A8-mediated PIT. The respective mean 
tumor sizes were 10.5 ± 1.0 mm for vehicle alone mice, 
10.8 ± 1.1 mm for mice treated with NIR laser alone, 
and 10.6 ± 2.1 mm for mice treated with IR700-12A8 
alone. The mean tumor size of mice treated with 
IR700-12A8-mediated PIT (2.2 ± 2.7 mm) was 
significantly smaller than that of the other groups of 
mice (p<0.01).  
Mechanism of IR700-12A8-mediated PIT in 
vitro 
 To investigate the underlying mechanism of cell 
death triggered by IR700-12A8-mediated PIT, 
GIST-T1 cells treated with IR700-12A8-mediated PIT 
were analyzed by annexin V-FITC and PI staining. 
When the cells were treated with vehicle alone or 
IR700-12A8 alone, the percentage of annexin V 
positive and PI negative (annexin V (+) and PI (-)) or 
both annexin V and PI positive (annexin V (+) and PI 
(+)) cells was very low. When the cells were treated 
with IR700-12A8-mediated PIT, the percentage of 
annexin V (+) and PI (-) cells was 18%, 24%, 20% and 
16% at 1, 6, 12 and 24 h, respectively, after irradiation. 
Meanwhile, the percentage of annexin V (+) and PI (+) 
cells was 33%, 35%, 51% and 80% at 1, 6, 12, and 24 h, 
respectively, after irradiation (Fig. 5A). These results 
indicate that in about 30% of the treated cells, rapid 
cell death, such as necrosis, was induced. However, 
annexin V (+) and PI (-) cells were consistently seen 
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until 24 h after irradiation and these cells gradually 
shifted to late apoptotic phase (annexin V (+) and PI 
(+)), suggesting that late apoptotic cell death also 
contributed to the mechanism of cell death in our 
condition.  
 Therefore, we next assessed apoptosis using 
GIST-T1 and GIST-882M cells treated with IR700- 
12A8-mediated PIT by Western blotting for cleaved 
PARP and Bcl-2. Treatment with IR700-12A8 and NIR 
irradiation resulted in increased PARP cleavage in 
both GIST cell lines, while the antiapoptotic factor 
Bcl-2, which was only expressed in GIST-T1 cells, 
decreased after treatment (Fig. 5B). To clarify the role 
of ROS in inducing apoptosis with IR700-12A8- 
mediated PIT, sodium azide (NaN3), a specific 
quencher of singlet oxygen, or NAC, a well-known 
scavenger of ROS, was added to the medium when 
cells were irradiated with NIR light. Twenty-four 
hours after irradiation, the percentage of dead cells 
was significantly decreased in the presence of NaN3 
compared with untreated cells (vehicle alone) in a 
dose-dependent manner, while only partial reduction 
of phototoxicity was observed in the presence of NAC 
(Fig. 5C). Furthermore, the expression of cleaved 
PARP was not increased when the cells were treated 
with IR700-12A8-mediated PIT in the presence of 
NaN3 (Fig. 5D). These results indicate that IR700- 
12A8-mediated PIT induced apoptosis through 
accumulation of ROS, especially singlet oxygen, in 
GIST cells. 
Apoptosis induced by in vivo IR700-12A8- 
mediated PIT 
 To assess the in vivo relevance of apoptosis 
following IR700-12A8-mediated PIT, GIST-T1- 
xenografted mice received IR700-12A8-mediated PIT, 
and histopathological analysis and TUNEL staining 
were performed at the timepoints indicated in Fig. 6A. 
Representative photomicrographs of sections from 
excised tumors are shown in Fig. 6B. Many apoptotic 
cells with altered nuclear morphology and chromatin 
aggregation were observed throughout the tumors 
from the treatment group. In contrast, many typical 
spindle-shaped GIST cells and far fewer apoptotic 
cells were observed in the non-treatment group. 
TUNEL staining revealed many apoptotic cells in 
tumors from mice treated with IR700-12A8-mediated 
PIT at 100, 200, and 300 J/cm2 (Fig. 6C). The apoptotic 
index in tumors from mice treated with IR700-12A8 
without irradiation was only 3.4%, while it was 
significantly increased to 28.8%, 57.9%, and 14.7% 
after irradiation with NIR light at 100, 200, and 300 
J/cm2, respectively (Fig. 6D). These results indicate 
that IR700-12A8-mediated PIT induced apoptosis in 
GIST cells in an in vivo mouse model, as well as in 
vitro.  
Discussion  
 In this study, we clearly visualized GIST cells in 
vitro and in a mouse xenograft model with high 
specificity using an NIR photosensitizer-conjugated 
anti-c-KIT antibody IR700-12A8. We also detected 
strong fluorescence signals from GIST through the 
covered normal mucosa under AFI endoscopy in an 
orthotopically transplanted GIST rat model after 
injection of fluorophore-conjugated anti-c-KIT 
antibody. This is the first report of endoscopic 
fluorescence imaging of GIST. Moreover, PIT in 
combination with IR700-12A8 and NIR irradiation 
showed a strong antitumor effect against GIST cells in 
vitro and in vivo, resulting in complete disappearance 
of more than half of all tumors in the xenograft model. 
Thus, our results raise the possibility that NIR 
fluorescence imaging targeting c-KIT using IR700- 
12A8 in combination with NIR irradiation may 
become an effective theranostic for GIST. Addition-
ally, 2 potential mechanisms of cell death were 
suggested in our condition of PIT experiments, 
namely acute necrotic cell death and late apoptotic 
cell death via production of singlet oxygen. 
 Generally, conventional PDT using photosens-
itizers requires protection of the skin and eyes from 
direct sunlight since the photosensitizers accumulate 
non-specifically in normal tissue [16,17]. Esophageal 
cancer patients who are treated with PDT using the 
photosensitizer talaporfin sodium (Laserphyrin®) are 
advised to avoid direct sunlight for 2 weeks. 
However, IR700-conjugated anti-c-KIT antibody does 
not require sunlight avoidance because it specifically 
binds to c-KIT in GIST, and c-KIT is not expressed in 
normal skin and eyes. It is important that IR700-12A8 
binds specifically to c-KIT on the cell membrane or is 
internalized to the cytoplasm of GIST cells for 
tumor-specific and effective PIT because the half-life 
of singlet oxygen generated by irradiation is very 
short (<0.04 µs) and its radius of action is only <0.02 
µm [17]. Conversely, the singlet oxygen produced by 
circulating IR700-12A8 irradiated in the blood of 
normal tissues causes much less cell damage. In fact, 
adverse events such as cutaneous damage were not 
observed after therapy even in the site where the GIST 
was xenografted. Thus, we surmise that a major 
advantage of our PIT method for GIST is that it 
eliminates the need for sunlight avoidance during 
treatment. In addition, since the quantum yield of 
IR700 for production of fluorescence is relatively 
higher (0.44) than that of singlet oxygen (<0.03) 
[32–34], we are able to minimally irradiate with NIR 
light for imaging guidance to avoid tissue damage, 
and to irradiate more strongly for treatment. 
 Theranostics 2018, Vol. 8, Issue 9 
 
 
http://www.thno.org 
2323 
 
Figure 4. Antitumor effect of IR700-12A8-mediated NIR irradiation. (A) Percentage of dead GIST-T1 cells treated with IR700-12A8 and NIR laser irradiation. Cells 
were incubated with IR700-12A8 for 6 h at 37°C, and then irradiated with NIR light. Cell viability was assessed by WST-8 assay at 1, 24, or 48 h after irradiation. (n=4; 
**p <0.01 by Dunnett’s test) and the percentage of dead cells was calculated as 100% minus the percentage of live cells. (B) Treatment regimen for in vivo 
IR700-12A8-mediated NIR laser irradiation therapy. Alexa Fluor 647-conjugated anti-c-KIT antibody (AF647-antibody) was injected at day 28 and the tumor was 
observed using the IVIS Spectrum at day 30, after which the mice were sacrificed for histological analysis. (C) Chronological changes of relative tumor volume in the 
IR700-12A8 + laser group, IR700-12A8 alone group, laser alone group, and vehicle alone group (n=7 per group). Relative tumor volume (RTV) was calculated using 
the following formula: RTV = tumor volume at day X / tumor volume at day 0. (**p<0.01 by Dunnett’s test) (D) Representative images of vehicle-injected mice (left 
panel) and IR700-12A8-injected mice (right panel) at day 30. Right-side tumors in each mouse were irradiated, while left-side tumors were not irradiated. White-light 
images (upper) and fluorescence images (lower) were obtained at 48 h after injection of AF647-antibody. (E) Tumors resected from vehicle-injected group (N1–7) 
and IR700-12A8-injected group (T1–7) at day 30. 
 
NIR light at wavelengths of 700-1100 nm has 
much better optical penetration as compared with 
shorter-wavelength light [35]. Theodore and 
associates reported that NIR light penetrated up to 30 
mm through several types of human soft tissues [36]. 
Accordingly, NIR light is very suitable for 
fluorescence-mediated diagnosis and therapy of 
submucosal lesions such as GIST. Additionally, 4.6% 
to 46% of initial light at 600-700 nm reportedly 
remains at a depth of 5-20 mm [37]. Therefore, the 
entirety of xenograft tumors 6-7 mm in diameter 
could be easily irradiated by NIR laser, and such 
tumors appeared to undergo almost complete 
disappearance. However, it seems that NIR light does 
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not sufficiently reach distant organs such as liver and 
kidney through the muscle layer of the gastro-
intestinal (GI) tract and peritoneum from the mucosal 
side of the GI tract (stomach, etc.). Moreover, our 
biodistribution data for IR700-12A8 revealed very low 
fluorescence signals in other organs including liver 
and kidney (Fig. S8). Therefore, damage of these 
organs by NIR light emitted from the endoscope 
would likely be minimal.  
 
 
Figure 5. Apoptosis assay and cell death assessment for investigating the therapeutic mechanism of IR700-12A8-mediated NIR irradiation therapy in vitro. (A) 
Annexin V-FITC and propidium iodide (PI) staining of GIST-T1 cells treated with vehicle alone, IR700-12A8 alone, or IR700-12A8 + NIR laser (100 J/cm2). The cells 
were stained 1, 6, 12, and 24 h after irradiation and were analyzed by flow cytometry. (B) Cleaved PARP and Bcl-2 expression in GIST cells treated with IR700-12A8 
and NIR laser irradiation (mAb + Laser). The cells were treated with IR700-12A8 and NIR laser irradiation (20 J/cm2) or vehicle alone (Ctrl), and subjected to 
Western blot analysis for cleaved PARP and Bcl-2. β-actin was used as a loading control. (C) Cell death evaluation of GIST cells treated with IR700-12A8 and NIR laser 
irradiation. GIST-T1 cells pre-incubated with IR700-12A8 were incubated with vehicle, N-acetyl-l-cysteine (NAC), or sodium azide (NaN3) for 1 h, and then were 
irradiated (20 J/cm2 or 100 J/cm2). Cell viability was evaluated 24 h later by WST-8 assay and the percentage of dead cells was calculated as 100% minus the percentage 
of live cells. Data represent mean ± SD (n=3; **p <0.01 by Dunnett’s test). (D) The effect of NaN3 on the expression of cleaved PARP. GIST-T1 cells treated with 
vehicle (no treatment), IR700-12A8 and NaN3, IR700-12A8 and NIR irradiation, or IR700-12A8 and NaN3 and NIR irradiation were subjected to Western blot 
analysis. 
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Figure 6. Histological analysis and TUNEL staining of xenografted tumors treated with IR700-12A8-mediated NIR irradiation. (A) Treatment regimen for histological 
analysis of in vivo NIR laser irradiation therapy. (B) Hematoxylin and eosin (H&E) staining of GIST-T1 tumors resected from non-treated mice (Ctrl) and 
IR700-12A8-mediated NIR irradiated mice (mAb + Laser). Original magnification, ×200. The high-magnification image is shown in the inset (×1000). (C, D) TUNEL 
staining and apoptotic index of GIST-T1 tumors treated with IR700-12A8 alone (mAb alone) or IR700-12A8-mediated NIR irradiation (mAb + Laser) at 100-300 
J/cm2. Original magnification, ×400. Apoptotic index was calculated in 3 randomly selected fields of each tumor section. Data represent mean ± SD (n=3; **p <0.01 
by Dunnett’s test). 
 
In this study, we used a relatively high dose (in 
Joules) of NIR light irradiation for effective PIT of 
GIST (10-100 J/cm2 on cells and 3×100 J/cm2 on 
tumors) compared with previous studies [38–40]. 
There are several likely reasons why high-dose 
irradiation was required in this study. First, the 
anti-c-KIT antibody (12A8) used in this study induces 
a rapid internalization of c-KIT receptor to the 
cytoplasm. Harada and colleagues reported that the 
internalized fraction of IR700 was less efficient than 
the cell surface-bound IR700 fraction and had delayed 
cytotoxic effects probably due to the involvement of 
more singlet oxygen-dependent apoptotic processes 
[39]. Thus, we speculate that internalized IR700-12A8 
required a higher dose of NIR irradiation. Second, 
GIST is a sarcoma that is generally more resistant to 
both radiation and cytotoxic anti-cancer agents as 
compared with cancer cells. Although no previous 
studies on PIT for GIST cells have been reported, it is 
plausible that GIST cells would be more resistant to 
PIT than other cancer cells.  
 The therapeutic mechanism of conventional 
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PDT has been previously reported: when photo-
sensitizer that has accumulated intracellularly is 
excited by specific light, singlet oxygen is generated, 
which damages intracellular organelles leading to 
apoptotic cell death [15]. However, PIT has been 
reported to induce acute necrotic cell death [18,41]. 
Furthermore, Mitsunaga and colleagues examined 
apoptosis in an epidermoid carcinoma cell line (A431) 
in vitro immediately following PIT with IR700- 
conjugated anti-EGFR antibody and NIR irradiation, 
but the apoptotic indices were only 5% at 1 h and 18% 
at 8 h after irradiation, and it was concluded that the 
mechanism of cell death by PIT does not involve 
apoptosis [18]. In the present study, we also found 
that 30-60% of GIST cells underwent early cell death 
such as necrosis at 1 h after irradiation, but some of 
the remaining cells slowly underwent apoptosis and 
then shifted to a late-death fraction in flow cytometry. 
Regarding apoptosis, PARP cleavage was observed in 
our in vitro PIT experiments and it was suppressed by 
the singlet oxygen scavenger NaN3. However, NaN3 
could not completely restore the cells in this study, 
consistent with previous studies, suggesting that the 
remaining cell death might be caused by acute cell 
damage [42,43]. Moreover, with in vivo PIT, 
approximately 30%, 60%, and 30% of cells exhibited 
apoptosis at 1 day after the first, second, and third 100 
J/cm2 irradiations, respectively, in the TUNEL assay 
(Fig. 6D). These data demonstrate that IR700-12A8- 
mediated PIT caused apoptotic cell death, which 
differs from the findings of Mitsunaga and colleagues, 
in GIST tumors under our PIT conditions [18]. The 
antibody used in the present study (IR700-12A8) 
induced rapid c-kit receptor internalization to the 
cytoplasm of GIST cells (Fig.1C), which might have 
contributed to apoptotic cell death in the late phase 
after PIT, consistent with the findings of Harada and 
associates [39]. The eventual decrease in the apoptotic 
index after the third irradiation at 100 J/cm2 was 
thought to be due to remaining PIT-resistant tumor 
cells in the tumor, as well as monoclonal antibody 
clearance since the half-life of IR700-12A8 after 
injection was approximately 72 h (Fig. 2C). We also 
measured temperature changes in cells and 
xenografted tumors using a thermometer and found 
that the temperatures in the cells and tumors did not 
increase during laser therapy (Fig. S12), suggesting 
that temperature elevation is not an important factor 
in PIT under our conditions. 
 Recently, conventional PDT has been reported to 
activate autophagy in colorectal, breast, and other 
types of cancers [44,45]. Furthermore, Wei and 
associates reported that autophagy promotes 
resistance to apoptosis in colorectal cancer cells [44]. 
We also examined autophagy activation in GIST cells 
in vivo during PIT using LC3 as a marker and found 
that LC3 punctate was much more evident in tumors 
irradiated at 200-300 J/cm2 (Fig. S13A), and that 
LC3-II expression was increased at 6, 12, and 24 h 
after PIT in vitro (Fig. S13B), indicating activation of 
autophagy by IR700-12A8-mediated PIT [46,47]. 
However, the autophagy inhibitor chloroquine did 
not significantly affect cleaved PARP expression. 
These results suggest that autophagy was induced in 
GISTs by PIT, but apoptotic cell death was not 
substantially affected by autophagy.  
 Currently, an AFI endoscope system (500-630 
nm; GIF-FQ260Z, Olympus, Co.) is available 
commercially, while no NIR fluorescence endoscopic 
system has yet reached this stage of development. We 
previously developed an infrared fluorescence endo-
scope to observe cancerous lesions using indocyanine 
green [48–50]. Slight modification of the observation 
filter to adjust for the wavelength of IR700 would 
enable observation of GIST under NIR fluorescence 
endoscopy with IR700-12A8. Additionally, when 
whole-body optical fluorescence imaging systems 
such as IVIS become available, NIR imaging with 
IR700-12A8 could become a useful method for 
detecting not only primary GIST lesions but also 
associated liver or intraperitoneal metastasis. The 
pharmacokinetics and pharmacodynamics of 
IR700-12A8, however, require further investigation 
prior to clinical application. Since 12A8 is a murine 
anti-c-KIT antibody, humanization of this antibody, 
which is currently underway, will be needed for 
clinical use.  
 In summary, we demonstrated that anti-c-KIT 
antibody conjugated with the NIR photosensitizer 
IR700-12A8 provided clear fluorescence imaging of 
GISTs in vitro and in vivo. We also clearly visualized 
GISTs in an orthotopically transplanted rat model 
through the covered normal mucosa using a 
fluorophore-conjugated anti-c-KIT antibody under 
AFI endoscopy. Moreover, IR700-12A8-mediated PIT 
was very effective for the treatment of GISTs, and the 
mechanism of this therapeutic effect involved acute 
necrotic cell death and supposedly late apoptotic cell 
death via production of singlet oxygen. Thus, our data 
indicate that IR700-conjugated anti-c-KIT antibodies 
and NIR irradiation therapy could be a novel effective 
theranostic technology for GISTs. 
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